3 Diskussion
5. Literatur
1. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH,
Hindricks G, Kirchhof P, Guidelines ESCCfP. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J
2012;33(21):2719-47.
2. Lip GY, Laroche C, Ioachim PM, Rasmussen LH, Vitali-Serdoz L, Petrescu L, Darabantiu D, Crijns HJ, Kirchhof P, Vardas P, Tavazzi L, Maggioni AP, Boriani G. Prognosis and treatment of atrial fibrillation patients by European cardiologists: One Year Follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry). Eur Heart J 2014;35(47):3365-76.
3. Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, Alasady M, Hanley L, Antic NA, McEvoy RD, Kalman JM, Abhayaratna WP, Sanders P. Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation: The ARREST-AF Cohort Study. J Am Coll Cardiol 2014;64(21):2222-31.
4. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD, Atrial Fibrillation Follow-up Investigation of Rhythm Management I. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med
2002;347(23):1825-33.
5. Hagens VE, Crijns HJ, Van Veldhuisen DJ, Van Den Berg MP, Rienstra M, Ranchor AV, Bosker HA, Kamp O, Tijssen JG, Veeger NJ, Van Gelder IC, group RACvEcfpafs. Rate control versus rhythm control for patients with
persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study. Am Heart J 2005;149(6):1106-11.
6. Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, Walter S, Tebbe U, Investigators S. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003;41(10):1690-6.
7. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ, Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study G. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347(23):1834-40.
8. Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, Josephson RA, Kellen JC, Klein RC, Krahn AD, Mickel M, Mitchell LB, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG, Investigators A. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.
Circulation 2004;109(12):1509-13.
9. Calkins H. Catheter ablation to maintain sinus rhythm. Circulation 2012;125(11):1439-45.
10. Neuberger HR, Tilz RR, Bonnemeier H, Deneke T, Estner HL, Kriatselis C, Kuniss M, Luik A, Sommer P, Steven D, von Bary C, Voss F, Eckardt L. A survey of German centres performing invasive electrophysiology: structure, procedures, and training positions. Europace 2013;15(12):1741-6.
11. Reynolds MR, Walczak J, White SA, Cohen DJ, Wilber DJ. Improvements in
70
treated with radiofrequency catheter ablation versus antiarrhythmic drugs. Circ Cardiovasc Qual Outcomes 2010;3(6):615-23.
12. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G,
Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339(10):659-66.
13. Themistoclakis S, Raviele A, China P, Pappone C, De Ponti R, Revishvili A, Aliot E, Kuck KH, Hoff PI, Shah D, Almendral J, Manolis AS, Chierchia GB, Oto A, Vatasescu RG, Sinkovec M, Cappato R, Atrial Fibrillation Survey I.
Prospective European survey on atrial fibrillation ablation: clinical
characteristics of patients and ablation strategies used in different countries. J Cardiovasc Electrophysiol 2014;25(10):1074-81.
14. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ, Jr., Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H,
Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D. 2012 HRS/EHRA/ECAS expert consensus statement on
catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up,
definitions, endpoints, and research trial design. J Interv Card Electrophysiol 2012;33(2):171-257.
15. Neumann T, Wojcik M, Berkowitsch A, Erkapic D, Zaltsberg S, Greiss H, Pajitnev D, Lehinant S, Schmitt J, Hamm CW, Pitschner HF, Kuniss M.
Cryoballoon ablation of paroxysmal atrial fibrillation: 5-year outcome after single procedure and predictors of success. Europace 2013;15(8):1143-9.
16. Metzner A, Wissner E, Schmidt B, Chun J, Hindricks G, Piorkowski C, Ouyang F, Kuck KH. Acute and long-term clinical outcome after endoscopic pulmonary vein isolation: results from the first prospective, multicenter study. J
Cardiovasc Electrophysiol 2013;24(1):7-13.
17. Rolf S, Boldt LH, Parwani AS, Wutzler A, Huemer M, Blaschke D, Herberger E, Haverkamp W. Findings and outcome of fluoroscopic visualization of the oesophageal course during catheter ablation of atrial fibrillation. Europace 2011;13(6):796-802.
18. Huemer M, Wutzler A, Parwani AS, Attanasio P, Haverkamp W, Boldt LH.
Mapping of the left-sided phrenic nerve course in patients undergoing left atrial catheter ablations. Pacing Clin Electrophysiol 2014;37(9):1141-8.
19. Latchamsetty R, Morady F. Long-term benefits following catheter ablation of atrial fibrillation. Circ J 2013;77(5):1091-6.
20. Kowalski M, Grimes MM, Perez FJ, Kenigsberg DN, Koneru J, Kasirajan V, Wood MA, Ellenbogen KA. Histopathologic characterization of chronic
radiofrequency ablation lesions for pulmonary vein isolation. J Am Coll Cardiol 2012;59(10):930-8.
21. Kornej J, Husser D, Bollmann A, Lip GY. Rhythm outcomes after catheter ablation of atrial fibrillation. Clinical implication of biomarkers.
Hamostaseologie 2014;34(1):9-19.
22. Hussein AA, Saliba WI, Martin DO, Shadman M, Kanj M, Bhargava M, Dresing T, Chung M, Callahan T, Baranowski B, Tchou P, Lindsay BD, Natale A,
Wazni OM. Plasma B-type natriuretic peptide levels and recurrent arrhythmia
72
after successful ablation of lone atrial fibrillation. Circulation 2011;123(19):2077-82.
23. von Haehling S, Filippatos GS, Papassotiriou J, Cicoira M, Jankowska EA, Doehner W, Rozentryt P, Vassanelli C, Struck J, Banasiak W, Ponikowski P, Kremastinos D, Bergmann A, Morgenthaler NG, Anker SD. Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure. Eur J Heart Fail 2010;12(5):484-91.
24. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F,
Kholmovski E, Burgon N, Hu N, Mont L, Deneke T, Duytschaever M, Neumann T, Mansour M, Mahnkopf C, Herweg B, Daoud E, Wissner E, Bansmann P, Brachmann J. Association of atrial tissue fibrosis identified by delayed
enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.
JAMA 2014;311(5):498-506.
25. Donal E, Behagel A, Feneon D. Value of left atrial strain: a highly promising field of investigation. Eur Heart J Cardiovasc Imaging 2014.
26. Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov 2009;8(10):794-805.
27. Harris TR, Hammock BD. Soluble epoxide hydrolase: gene structure, expression and deletion. Gene 2013;526(2):61-74.
28. Monti J, Fischer J, Paskas S, Heinig M, Schulz H, Gosele C, Heuser A, Fischer R, Schmidt C, Schirdewan A, Gross V, Hummel O, Maatz H, Patone G, Saar K, Vingron M, Weldon SM, Lindpaintner K, Hammock BD, Rohde K, Dietz R, Cook SA, Schunck WH, Luft FC, Hubner N. Soluble epoxide
hydrolase is a susceptibility factor for heart failure in a rat model of human disease. Nat Genet 2008;40(5):529-37.
29. Przybyla-Zawislak BD, Srivastava PK, Vazquez-Matias J, Mohrenweiser HW, Maxwell JE, Hammock BD, Bradbury JA, Enayetallah AE, Zeldin DC, Grant DF. Polymorphisms in human soluble epoxide hydrolase. Mol Pharmacol 2003;64(2):482-90.
30. Hoffmayer KS, Gerstenfeld EP. Contact force-sensing catheters. Curr Opin Cardiol 2015;30(1):74-80.
31. Akca F, Janse P, Theuns DA, Szili-Torok T. A prospective study on safety of catheter ablation procedures: Contact force guided ablation could reduce the risk of cardiac perforation. Int J Cardiol 2015;179:441-8.
32. Datino T, Arenal A, Pelliza M, Hernandez-Hernandez J, Atienza F, Gonzalez-Torrecilla E, Avila P, Bravo L, Fernandez-Aviles F. Comparison of the safety and feasibility of arrhythmia ablation using the Amigo Robotic Remote Catheter System versus manual ablation. Am J Cardiol 2014;113(5):827-31.
33. Lopez-Gil M, Salgado R, Merino JL, Datino T, Figueroa J, Arenal A, Mejia E, Salguero R, Fontenla A, Arribas F. Cavo-tricuspid isthmus radiofrequency ablation using a novel remote navigation catheter system in patients with typical atrial flutter. Europace 2014;16(4):558-62.
34. Dewire J, Calkins H. State-of-the-art and emerging technologies for atrial fibrillation ablation. Nat Rev Cardiol 2010;7(3):129-38.
35. Shurrab M, Schilling R, Gang E, Khan EM, Crystal E. Robotics in invasive cardiac electrophysiology. Expert Rev Med Devices 2014;11(4):375-81.
36. de Bakker JM, Ho SY, Hocini M. Basic and clinical electrophysiology of pulmonary vein ectopy. Cardiovasc Res 2002;54(2):287-94.
37. Kapa S, Venkatachalam KL, Asirvatham SJ. The autonomic nervous system in cardiac electrophysiology: an elegant interaction and emerging concepts.
74
38. Narayan SM, Krummen DE, Clopton P, Shivkumar K, Miller JM. Direct or coincidental elimination of stable rotors or focal sources may explain
successful atrial fibrillation ablation: on-treatment analysis of the CONFIRM trial (Conventional ablation for AF with or without focal impulse and rotor modulation). J Am Coll Cardiol 2013;62(2):138-47.
39. Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, Khunnawat C, Ngarmukos T. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004;43(11):2044-53.
40. Rajappan K, Ginks M. Catheter ablation of persistent atrial fibrillation. Future Cardiol 2014;10(4):553-62.
41. Rolf S, Kircher S, Arya A, Eitel C, Sommer P, Richter S, Gaspar T, Bollmann A, Altmann D, Piedra C, Hindricks G, Piorkowski C. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial
fibrillation. Circ Arrhythm Electrophysiol 2014;7(5):825-33.
42. Roten L, Derval N, Pascale P, Scherr D, Komatsu Y, Shah A, Ramoul K, Denis A, Sacher F, Hocini M, Haissaguerre M, Jais P. Current hot potatoes in atrial fibrillation ablation. Curr Cardiol Rev 2012;8(4):327-46.
43. Swarup V, Baykaner T, Rostamian A, Daubert JP, Hummel J, Krummen DE, Trikha R, Miller JM, Tomassoni GF, Narayan SM. Stability of Rotors and Focal Sources for Human Atrial Fibrillation: Focal Impulse and Rotor Mapping
(FIRM) of AF Sources and Fibrillatory Conduction. J Cardiovasc Electrophysiol 2014;25(12):1284-92.
44. D'Ascenzo F, Corleto A, Biondi-Zoccai G, Anselmino M, Ferraris F, di Biase L, Natale A, Hunter RJ, Schilling RJ, Miyazaki S, Tada H, Aonuma K, Yenn-Jiang L, Tao H, Ma C, Packer D, Hammill S, Gaita F. Which are the most reliable
predictors of recurrence of atrial fibrillation after transcatheter ablation?: a meta-analysis. Int J Cardiol 2013;167(5):1984-9.
45. Balk EM, Garlitski AC, Alsheikh-Ali AA, Terasawa T, Chung M, Ip S. Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a
systematic review. J Cardiovasc Electrophysiol 2010;21(11):1208-16.
46. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 1999;100(1):87-95.
47. Kottkamp H. Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy. Eur Heart J 2013;34(35):2731-8.
48. Kurosaki K, Tada H, Hashimoto T, Ito S, Miyaji K, Naito S, Oshima S, Taniguchi K. Plasma natriuretic peptide concentrations as a predictor for successful catheter ablation in patients with drug-refractory atrial fibrillation.
Circ J 2007;71(3):313-20.
49. Shin DI, Deneke T, Gorr E, Anders H, Buenz K, Paesler M, Horlitz M.
Predicting successful pulmonary vein isolation in patients with atrial fibrillation by brain natriuretic Peptide plasma levels. Indian Pacing Electrophysiol J 2009;9(5):241-6.
50. Mohanty S, Mohanty P, Di Biase L, Rong B, Burkhardt D, Gallinghouse JG, Horton R, Sanchez JE, Bailey S, Zagrodzky J, Natale A. Baseline B-type natriuretic peptide: a gender-specific predictor of procedure-outcome in atrial fibrillation patients undergoing catheter ablation. J Cardiovasc Electrophysiol 2011;22(8):858-65.
51. Potocki M, Ziller R, Mueller C. Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker? Curr Heart Fail Rep
76
52. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation
1995;92(7):1954-68.
53. Rostock T, Steven D, Lutomsky B, Servatius H, Drewitz I, Klemm H, Mullerleile K, Ventura R, Meinertz T, Willems S. Atrial fibrillation begets atrial fibrillation in the pulmonary veins on the impact of atrial fibrillation on the
electrophysiological properties of the pulmonary veins in humans. J Am Coll Cardiol 2008;51(22):2153-60.
54. Boldt LH, Rolf S, Dietz R, Haverkamp W. [Atrial fibrillation in patients with heart failure. Pathophysiological concepts and therapeutic options]. Dtsch Med Wochenschr 2008;133(45):2349-54.
55. McGann C, Akoum N, Patel A, Kholmovski E, Revelo P, Damal K, Wilson B, Cates J, Harrison A, Ranjan R, Burgon NS, Greene T, Kim D, Dibella EV, Parker D, Macleod RS, Marrouche NF. Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol 2014;7(1):23-30.
56. Vieira MJ, Teixeira R, Goncalves L, Gersh BJ. Left atrial mechanics:
echocardiographic assessment and clinical implications. J Am Soc Echocardiogr 2014;27(5):463-78.
57. Morris DA, Otani K, Bekfani T, Takigiku K, Izumi C, Yuda S, Sakata K, Ohte N, Tanabe K, Friedrich K, Kuhnle Y, Nakatani S, Otsuji Y, Haverkamp W, Boldt LH, Takeuchi M. Multidirectional global left ventricular systolic function in normal subjects and patients with hypertension: multicenter evaluation. J Am Soc Echocardiogr 2014;27(5):493-500.
58. Morris DA, Boldt LH, Eichstadt H, Ozcelik C, Haverkamp W. Myocardial systolic and diastolic performance derived by 2-dimensional speckle tracking
echocardiography in heart failure with normal left ventricular ejection fraction.
Circ Heart Fail 2012;5(5):610-20.
59. Cheung YF. The role of 3D wall motion tracking in heart failure. Nat Rev Cardiol 2012;9(11):644-57.
60. Motoki H, Negishi K, Kusunose K, Popovic ZB, Bhargava M, Wazni OM, Saliba WI, Chung MK, Marwick TH, Klein AL. Global left atrial strain in the prediction of sinus rhythm maintenance after catheter ablation for atrial fibrillation. J Am Soc Echocardiogr 2014;27(11):1184-92.
61. Montserrat S, Gabrielli L, Bijnens B, Borras R, Berruezo A, Poyatos S, Brugada J, Mont L, Sitges M. Left atrial deformation predicts success of first and second percutaneous atrial fibrillation ablation. Heart Rhythm
2015;12(1):11-8.
62. Loghin C, Karimzadehnajar K, Ekeruo IA, Mukerji SS, Memon NB, Kantharia BK. Outcome of pulmonary vein isolation ablation for paroxysmal atrial fibrillation: predictive role of left atrial mechanical dyssynchrony by speckle tracking echocardiography. J Interv Card Electrophysiol 2014;39(1):7-15.
63. Hammerstingl C, Schwekendiek M, Momcilovic D, Schueler R, Sinning JM, Schrickel JW, Mittmann-Braun E, Nickenig G, Lickfett L. Left atrial deformation imaging with ultrasound based two-dimensional speckle-tracking predicts the rate of recurrence of paroxysmal and persistent atrial fibrillation after
successful ablation procedures. J Cardiovasc Electrophysiol 2012;23(3):247-55.
64. Machino-Ohtsuka T, Seo Y, Tada H, Ishizu T, Machino T, Yamasaki H, Igarashi M, Xu D, Sekiguchi Y, Aonuma K. Left atrial stiffness relates to left ventricular diastolic dysfunction and recurrence after pulmonary vein isolation
78
65. Mirza M, Caracciolo G, Khan U, Mori N, Saha SK, Srivathsan K, Altemose G, Scott L, Sengupta P, Jahangir A. Left atrial reservoir function predicts atrial fibrillation recurrence after catheter ablation: a two-dimensional speckle strain study. J Interv Card Electrophysiol 2011;31(3):197-206.
66. Hwang HJ, Choi EY, Rhee SJ, Joung B, Lee BH, Lee SH, Kim J, Lee MH, Jang Y, Chung N, Kim SS. Left atrial strain as predictor of successful outcomes in catheter ablation for atrial fibrillation: a two-dimensional myocardial imaging study. J Interv Card Electrophysiol 2009;26(2):127-32.
67. Schneider C, Malisius R, Krause K, Lampe F, Bahlmann E, Boczor S, Antz M, Ernst S, Kuck KH. Strain rate imaging for functional quantification of the left atrium: atrial deformation predicts the maintenance of sinus rhythm after catheter ablation of atrial fibrillation. Eur Heart J 2008;29(11):1397-409.
68. Kuppahally SS, Akoum N, Burgon NS, Badger TJ, Kholmovski EG,
Vijayakumar S, Rao SN, Blauer J, Fish EN, Dibella EV, Macleod RS, McGann C, Litwin SE, Marrouche NF. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ Cardiovasc Imaging 2010;3(3):231-9.
69. Wittkampf FH, Nakagawa H. RF catheter ablation: Lessons on lesions. Pacing Clin Electrophysiol 2006;29(11):1285-97.
70. Reddy VY, Shah D, Kautzner J, Schmidt B, Saoudi N, Herrera C, Jais P, Hindricks G, Peichl P, Yulzari A, Lambert H, Neuzil P, Natale A, Kuck KH. The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm 2012;9(11):1789-95.
71. Neuzil P, Reddy VY, Kautzner J, Petru J, Wichterle D, Shah D, Lambert H, Yulzari A, Wissner E, Kuck KH. Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ Arrhythm Electrophysiol 2013;6(2):327-33.
72. Piorkowski C, Eitel C, Rolf S, Bode K, Sommer P, Gaspar T, Kircher S, Wetzel U, Parwani AS, Boldt LH, Mende M, Bollmann A, Husser D, Dagres N, Esato M, Arya A, Haverkamp W, Hindricks G. Steerable versus nonsteerable sheath technology in atrial fibrillation ablation: a prospective, randomized study. Circ Arrhythm Electrophysiol 2011;4(2):157-65.
80